Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:RWLK

ReWalk Robotics (RWLK) Stock Price, News & Analysis

ReWalk Robotics logo

About ReWalk Robotics Stock (NASDAQ:RWLK)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.64
$1.25
52-Week Range
N/A
Volume
303,600 shs
Average Volume
541,468 shs
Market Capitalization
$63.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.

Receive RWLK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ReWalk Robotics and its competitors with MarketBeat's FREE daily newsletter.

RWLK Stock News Headlines

Lake Street Keeps Their Buy Rating on Rewalk Robotics (LFWD)
Lake Street Sticks to Its Buy Rating for Rewalk Robotics (LFWD)
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
ReWalk Robotics Ltd (2RW.MU)
ReWalk Robotics earnings: here's what Wall Street expects
See More Headlines

RWLK Stock Analysis - Frequently Asked Questions

ReWalk Robotics Ltd. (NASDAQ:RWLK) issued its earnings results on Thursday, November, 11th. The medical device company reported ($0.06) EPS for the quarter, meeting the consensus estimate of ($0.06). The medical device company earned $1.97 million during the quarter, compared to the consensus estimate of $1.60 million. ReWalk Robotics had a negative net margin of 238.35% and a negative trailing twelve-month return on equity of 29.00%.

Based on aggregate information from My MarketBeat watchlists, some other companies that ReWalk Robotics investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Calumet Specialty Products Partners (CLMT), Two Harbors Investment (TWO), NVIDIA (NVDA), Meta Platforms (META) and NovoCure (NVCR).

Company Calendar

Last Earnings
11/11/2021
Today
5/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
NASDAQ:RWLK
Fax
N/A
Employees
56
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$19.57 million
Net Margins
-238.35%
Pretax Margin
-233.51%

Debt

Sales & Book Value

Annual Sales
$5.51 million
Price / Cash Flow
N/A
Book Value
$1.10 per share
Price / Book
N/A

Miscellaneous

Free Float
58,764,000
Market Cap
$63.04 million
Optionable
Optionable
Beta
2.30
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:RWLK) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners